Feng Yufei, Mitsuhashi Shinya, Kishimoto Takao, Ubukata Makoto
Graduate School of Agriculture, Hokkaido University, North-9, West-9, Kita-ku, Sapporo 060-8589, Japan.
J Antibiot (Tokyo). 2005 Dec;58(12):759-65. doi: 10.1038/ja.2005.103.
High incorporation of D-[U-13C] glucose and L-[indole-2-13C] tryptophan into indocarbazostatin B (2) was observed in a biosynthetic study using a mutant strain, Streptomyces sp. MUV-7-8. The original strain, Streptomyces sp. TA-0403 produced a small amount of indocarbazostatin (1) and indocarbazostatin B (2), which displayed potent biological activities. To facilitate biosynthetic studies, we selected high indocarbazostatin producing mutant strains. The first mutants, Streptomyces sp. MUV-6-83 and MUV-6-17, produced indocarbazostatins C (3) and D (4) as well as 1 and 2. When the production medium was supplemented with D-tryptophan, the MUV-6-17 mutant produced K252c (5), whereas when L-tryptophan was added, it produced K252d (6). On further UV treatment of the mutant strain MUV-6-83, we finally obtained a new mutant producer, Streptomyces sp. MUV-7-8, that produced 2 as a major metabolite with higher productivity. This mutant producer enabled us to do a feeding experiment of the envisioned precursors, glucose and tryptophan.
在使用突变菌株链霉菌属MUV-7-8进行的生物合成研究中,观察到D-[U-13C]葡萄糖和L-[吲哚-2-13C]色氨酸大量掺入吲哚咔唑他汀B(2)中。原始菌株链霉菌属TA-0403产生少量吲哚咔唑他汀(1)和吲哚咔唑他汀B(2),它们具有强大的生物活性。为了促进生物合成研究,我们筛选出了高产吲哚咔唑他汀的突变菌株。最初的突变菌株链霉菌属MUV-6-83和MUV-6-17产生吲哚咔唑他汀C(3)和D(4)以及1和2。当在生产培养基中添加D-色氨酸时,MUV-6-17突变体产生K252c(5),而添加L-色氨酸时,它产生K252d(6)。对突变菌株MUV-6-83进一步进行紫外线处理后,我们最终获得了一个新的突变生产菌株链霉菌属MUV-7-8,它以更高的产量将2作为主要代谢产物产生。这个突变生产菌株使我们能够对预想的前体葡萄糖和色氨酸进行饲喂实验。